These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 22940241

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The Fight against Infection and Pain: Devil's Claw (Harpagophytum procumbens) a Rich Source of Anti-Inflammatory Activity: 2011-2022.
    Gxaba N, Manganyi MC.
    Molecules; 2022 Jun 06; 27(11):. PubMed ID: 35684573
    [Abstract] [Full Text] [Related]

  • 3. Analgesic, antiinflammatory and antidiabetic properties of Harpagophytum procumbens DC (Pedaliaceae) secondary root aqueous extract.
    Mahomed IM, Ojewole JA.
    Phytother Res; 2004 Dec 06; 18(12):982-9. PubMed ID: 15742343
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of Devil's Claw (Harpagophytum procumbens) on the multidrug transporter ABCB1/P-glycoprotein.
    Romiti N, Tramonti G, Corti A, Chieli E.
    Phytomedicine; 2009 Dec 06; 16(12):1095-100. PubMed ID: 19577448
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of the major glycosides of Harpagophytum procumbens (Devil's Claw) on epidermal cyclooxygenase-2 (COX-2) in vitro.
    Abdelouahab N, Heard C.
    J Nat Prod; 2008 May 06; 71(5):746-9. PubMed ID: 18412394
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dermal and transcutaneous delivery of the major glycoside constituents of Harpagophytum procumbens (Devil's Claw) in vitro.
    Abdelouahab N, Heard CM.
    Planta Med; 2008 Apr 06; 74(5):527-31. PubMed ID: 18401847
    [Abstract] [Full Text] [Related]

  • 12. Devil's claw (Harpagophytum procumbens) and chronic inflammatory diseases: A concise overview on preclinical and clinical data.
    Menghini L, Recinella L, Leone S, Chiavaroli A, Cicala C, Brunetti L, Vladimir-Knežević S, Orlando G, Ferrante C.
    Phytother Res; 2019 Sep 06; 33(9):2152-2162. PubMed ID: 31273865
    [Abstract] [Full Text] [Related]

  • 13. The commercial harvest of devil's claw (Harpagophytum spp.) in southern Africa: the devil's in the details.
    Stewart KM, Cole D.
    J Ethnopharmacol; 2005 Sep 14; 100(3):225-36. PubMed ID: 16112533
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Analysis and stability of the constituents of Curcuma longa and Harpagophytum procumbens tinctures by HPLC-DAD and HPLC-ESI-MS.
    Karioti A, Fani E, Vincieri FF, Bilia AR.
    J Pharm Biomed Anal; 2011 Jun 01; 55(3):479-86. PubMed ID: 21420820
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Quality Assessment of Commercial Spagyric Tinctures of Harpagophytum procumbens and Their Antioxidant Properties.
    Avato P, Argentieri MP.
    Molecules; 2019 Jun 17; 24(12):. PubMed ID: 31212908
    [Abstract] [Full Text] [Related]

  • 20. A novel ex vivo skin model for the assessment of the potential transcutaneous anti-inflammatory effect of topically applied Harpagophytum procumbens extract.
    Ouitas NA, Heard CM.
    Int J Pharm; 2009 Jul 06; 376(1-2):63-8. PubMed ID: 19383533
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.